Cybin Inc. (NEO:CYBN | NYSE American: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics®, today announced that the...
Cybin Inc. (NEO:CYBN) (NYSE American:CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics®, today reported unaudited...
The article News You Might Have Missed: Nov 14th, 2022 was originally published on Microdose. Welcome to the News You Might Have Missed, a weekly roundup...
October was a pretty brutal month for the psychedelic stock market no matter which way you look at it. While the rest of the stock market...
The article Atai Reports Q3 Financials and Business Update was originally published on Microdose. atai Life Sciences has the biggest product portfolio...
Filament Health Corp. (OTCQB: FLHLF | NEO: FH | FSE: 7QS), a clinical-stage natural psychedelic drug development company, released its second quarter...
The non-profit trade association received a high level of interest from multiple branches of government The post PsyCan aims to be ‘go-to’ psychedelics...
The non-profit trade association received a high level of interest from multiple branches of government The post PsyCan aims to be ‘go-to’ psychedelic...
Cybin Inc. (NEO:CYBN | (NYSE AMERICAN:CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics®, is pleased to announce...
LSD is back with a flurry of new applications to treat a broad array of conditions. The post LSD Finds New Life in Mental Health Circles...